 Importantly, this study will also evaluate the safety and tolerability of repeated microdoses of LSD, via measures of LSD pharmacokinetics and pharmacodynamics, including physiological markers of inflammation and neurogenesis.News reports in 2018-2019 indicated that the Foundation had been retained by the Canadian cannabis producer Canopy Growth Corporation to conduct research as to the benefits of various strains of its products, particularly in treating pain, anxiety and drug addiction.One goal is to reduce dependence on opioids in treating cancer-related pain.